Adherence to prescription of evidence based medications in patients with

IHD is associated with significant mortality and morbidity worldwide. International guidelines are established to recommend evidence based medications in this subset of patients. Adherence to evidence based medications reduce mortality and morbidity at both primary and secondary prevention level. There are global and inter-regional variations in the rate of adherence to these medications. The rate of adherence of physicians in Sudan to evidence based medications is largely unknown The Study: We conducted a retrospective study in Sudan Heart Institute(SHI), one of the leading cardiac centers in Sudan, on all patients with the diagnosis of IHD.We investigated the rate of adherence of Physicians to the prescription of evidence based medications at both the primary and secondary level. Results: 150 patients were included. 60 % were males and 40 % were females. Mean age of patients was 58 years. Upon admission 97 % of patients were prescribed asprin, 86 % beta-blocker, 96% clopidogrel, 95 % a statin and 80 % were prescribed an ACEI. There rate of prescription of these medications upon follow up was high and was not significantly lower than at admission